Allianz SE Boosts Stake in UnitedHealth Group by 27.6% to $23.1M

Allianz SE has significantly increased its investment in UnitedHealth Group Incorporated, raising its shareholding by 27.6% during the second quarter of 2023. According to a recent filing with the U.S. Securities and Exchange Commission, Allianz now owns 74,049 shares, having acquired an additional 16,016 shares during this period. This investment is valued at approximately $23.1 million.

The move is part of a broader trend among institutional investors who are also adjusting their holdings in UnitedHealth Group. Good Life Advisors LLC notably increased its stake by an impressive 396.7%, now owning 4,883 shares worth about $1.5 million, after purchasing an additional 3,900 shares. Other significant increases include ABN Amro Investment Solutions, which acquired a new position valued at around $10.4 million, and Cherokee Insurance Company, which invested approximately $1.8 million.

In addition, the Police & Firemen’s Retirement System of New Jersey raised its position by 3.2%, now holding 138,189 shares valued at $43.1 million. Geode Capital Management LLC also increased its stake by 3.3%, owning over 21.3 million shares worth approximately $6.6 billion. Altogether, institutional investors control 87.86% of UnitedHealth Group’s stock.

Stock Performance and Financials

UnitedHealth Group’s stock opened at $339.18 on Thursday, reflecting a 3.6% increase. Over the past year, the stock has fluctuated between a low of $234.60 and a high of $622.83. The company boasts a market capitalization of $307.25 billion and maintains a price-to-earnings (P/E) ratio of 17.70.

The healthcare conglomerate recently reported its quarterly earnings on October 28, 2023, revealing earnings per share (EPS) of $2.92, surpassing analysts’ expectations of $2.87 by $0.05. Revenue for the quarter reached $113.16 billion, slightly below projections of $113.19 billion. The company has achieved a net margin of 4.04% and a return on equity of 19.23%, with revenue growth of 12.2% compared to the same period last year. In the previous year, the company reported $7.15 EPS.

Dividend Announcement and Analyst Ratings

UnitedHealth Group has also announced a quarterly dividend of $2.21, set to be paid on December 16, 2023, to stockholders on record as of December 8, 2023. This dividend represents an annualized yield of 2.6% and a payout ratio of 46.14%.

Wall Street analysts remain optimistic about UnitedHealth Group’s future. Recently, JPMorgan Chase & Co. raised its price target from $310.00 to $425.00, giving the stock an “overweight” rating. Morgan Stanley and Royal Bank of Canada have also increased their price objectives, now at $395.00 and $408.00, respectively. Currently, eighteen analysts rate the stock as a Buy, while nine recommend holding and three suggest selling. The consensus price target stands at $397.12, according to data from MarketBeat.com.

As a diversified health care company, UnitedHealth Group operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The company’s broad range of services includes health benefit plans for various employer sizes and public sector entities, as well as specialized care for individuals, particularly those aged 50 and older, and Medicaid beneficiaries.

The recent moves by Allianz SE and other institutional investors reflect growing confidence in UnitedHealth Group’s stability and growth potential within the healthcare market.